Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study [0.03%]
晚期非小细胞肺癌患者的系统治疗模式：PIvotal研究
J de Castro,P Tagliaferri,V C C de Lima et al.
J de Castro et al.
The aim of this multinational retrospective cohort study, conducted at academic and community oncology centres, was to describe real-world treatment patterns for patients with a confirmed diagnosis of advanced/metastatic (stage IIIB/IV) non...
Observational Study
European journal of cancer care. 2017 Nov;26(6):e12734. DOI:10.1111/ecc.12734 2017
Exploring the provision of alcohol advice by clinicians to breast cancer patients [0.03%]
临床医生向乳腺癌患者提供酒精建议的研究
P Simapivapan,A Hodge,A Boltong
P Simapivapan
Interactions between clinicians and patients along the cancer trajectory provide an opportunity to deliver key messages regarding drinking behaviours and long-term health. This study aimed to explore the extent and nature of clinician-patie...
Developing an aftercare decision aid; assessing health professionals' and patients' preferences [0.03%]
一种术后护理决策支持工具的开发及对医护人员和患者偏好的评估研究
Linda Klaassen,Carmen Dirksen,Liesbeth Boersma et al.
Linda Klaassen et al.
Personalising aftercare for curatively treated breast cancer patients is expected to improve patient satisfaction with care. A patient decision aid can support women in making decisions about their aftercare trajectory, but is currently not...
Palliative care physicians' experiences of end-of-life communication: A focus group study [0.03%]
临终沟通的经验：一项焦点小组研究
C Udo,M Lövgren,G Lundquist et al.
C Udo et al.
The aim of this study was to explore palliative home care physicians' experiences regarding end-of-life breakpoint communication (BPC). This is a qualitative study where focus group interviews were conducted and analysed using qualitative c...
Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis [0.03%]
伊立替康/铂类与依托泊苷/铂类化疗治疗广泛期小细胞肺癌的比较：一项系统评价和meta分析
D Han,G Wang,L Sun et al.
D Han et al.
This meta-analysis was performed to compare the effects and toxicities between irinotecan/platinum (IP) and etoposide/platinum (EP) regimens as the fist-line treatment of patients with extensive-stage small cell lung cancer (E-SCLC). A syst...
Meta-Analysis
European journal of cancer care. 2017 Nov;26(6). DOI:10.1111/ecc.12723 2017
Psychological stress affects the severity of radiation-induced acute skin reactions in breast cancer patients [0.03%]
心理压力影响乳腺癌患者的放射性急性皮肤反应的严重程度
A E Sutherland,N C Bennett,P M Herst
A E Sutherland
Psychological stress exacerbates many pathological conditions including inflammatory skin conditions. The effect of psychological stress on acute radiation-induced skin reactions has not been documented before. Here, we aimed to explore if ...
Cost-effectiveness analysis of fulvestrant versus anastrozole as first-line treatment for hormone receptor-positive advanced breast cancer [0.03%]
氟维司群对比阿那曲唑治疗激素受体阳性晚期乳腺癌的成本效益分析
H Ding,L Fang,W Xin et al.
H Ding et al.
Although recent studies demonstrated that fulvestrant is superior to anastrozole as first-line treatment for hormone receptor (HR)-positive advanced breast cancer, the cost-effectiveness of fulvestrant versus anastrozole remained uncertain....
Comparative Study
European journal of cancer care. 2017 Nov;26(6). DOI:10.1111/ecc.12733 2017
V Innao,A Allegra,S Russo et al.
V Innao et al.
The assessment of the effectiveness of chemotherapy in oncology cannot disregard the concept of minimal residual disease (MRD). In fact, the efforts of numerous scientific groups all over the world are currently focusing on this issue, with...
Radiation therapy utilisation in patients with bone metastases secondary to prostate cancer: A multicenter study [0.03%]
前列腺癌继发骨转移患者放射治疗的使用情况：一项多中心研究
M M Mazzei,A Sindoni,A Santacaterina et al.
M M Mazzei et al.
Multicenter Study
European journal of cancer care. 2017 Jul;26(4). DOI:10.1111/ecc.12681 2017
Quality of life after bone sarcoma surgery around the knee: A long-term follow-up study [0.03%]
膝关节周围骨肉瘤术后长期随访的生活质量研究
W P Bekkering,J C van Egmond-van Dam,J A M Bramer et al.
W P Bekkering et al.
It remains unclear if quality of life (QoL) improvements could be expected in young patients after malignant bone tumour surgery after 2 years. To assess the course of QoL over time during a long-term follow-up, malignant bone tumour surviv...
Multicenter Study
European journal of cancer care. 2017 Jul;26(4). DOI:10.1111/ecc.12603 2017